|
DAZAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.99200722162641E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.80726569662693E-14 |
| Normal-vs-Stage2 |
5.3388999998738E-07 |
| Normal-vs-Stage3 |
2.27350000048254E-07 |
| Normal-vs-Stage4 |
1.804500E-04 |
| Stage1-vs-Stage2 |
6.322800E-01 |
| Stage1-vs-Stage3 |
6.376200E-01 |
| Stage1-vs-Stage4 |
2.235000E-01 |
| Stage2-vs-Stage3 |
9.499200E-01 |
| Stage2-vs-Stage4 |
3.439200E-01 |
| Stage3-vs-Stage4 |
3.497600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62470037423645E-12 |
| Normal-vs-AfricanAmerican |
1.89669999706155E-08 |
| Normal-vs-Asian |
8.064300E-03 |
| Caucasian-vs-AfricanAmerican |
1.172630E-01 |
| Caucasian-vs-Asian |
4.052400E-01 |
| AfricanAmerican-vs-Asian |
1.367170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
7.62420004907227E-09 |
| Male-vs-Female |
1.158580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.24429999637243E-08 |
| Normal-vs-Extreme_Weight |
3.08642000845794E-14 |
| Normal-vs-Obese |
5.48180389969843E-11 |
| Normal-vs-Extreme_Obese |
4.425200E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.599200E-01 |
| Normal_Weight-vs-Obese |
4.141600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.423200E-01 |
| Extreme_Weight-vs-Obese |
2.941600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.916600E-01 |
| Obese-vs-Extreme_Obese |
9.173800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.980500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.38480346581582E-11 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
1.427830E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.095000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.531000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.565800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.714000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.837600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.477200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.23132623489164E-12 |
| Normal-VS-Type2 PRCC |
1.62447832963153E-12 |
| Normal-VS-KIRP CIMP |
5.51729995024175E-09 |
| Normal-VS-Unclassified PRCC |
1.832620E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.623300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.797600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.190600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.870400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.264300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.599380E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.0197845052603E-12 |
| Normal-vs-N1 |
4.73199999961871E-07 |
| Normal-vs-N2 |
1.258550E-01 |
| N0-vs-N1 |
5.085000E-01 |
| N0-vs-N2 |
4.690600E-01 |
| N1-vs-N2 |
6.449000E-01 |
|
|
